SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 16,480.82 |
Enterprise Value ($M) | 16,812.66 |
Book Value ($M) | 4,951.55 |
Book Value / Share | 26.24 |
Price / Book | 3.33 |
NCAV ($M) | 1,066.03 |
NCAV / Share | 5.65 |
Price / NCAV | 15.46 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.03 |
Return on Assets (ROA) | 0.03 |
Return on Equity (ROE) | 0.04 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.57 |
Current Ratio | 2.51 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2,956.09 |
Assets | 6,841.60 |
Liabilities | 1,890.05 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 2,419.23 |
Operating Income | 171.60 |
Net Income | 167.65 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 159.26 |
Cash from Investing | -111.24 |
Cash from Financing | -18.73 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Dodge & Cox | 7.40 | -2.71 | |
13G/A | Vanguard Group Inc | 9.58 | 3.94 | |
13G/A | Primecap Management Co/ca/ | 9.78 | 4.74 | |
13G | Capital Research Global Investors | 5.70 | 90.67 | |
13G/A | BlackRock Inc. | 7.80 | -3.06 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
155,090 | 733,232 | 21.15 | |
163,160 | 801,797 | 20.35 | |
223,017 | 1,132,680 | 19.69 | |
218,029 | 1,228,676 | 17.75 | |
(click for more detail) |
Similar Companies | |
---|---|
BIIB – Biogen Inc. | BLUE – bluebird bio, Inc. |
BMEA – Biomea Fusion, Inc. | BOLT – Bolt Biotherapeutics, Inc. |
BPMC – Blueprint Medicines Corporation |
Financial data and stock pages provided by
Fintel.io